Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients

Clinical trial NCT01474382 · COMPLETED

Trial details

NCT number: NCT01474382
Sponsor: Novocol Pharmaceutical of Canada, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dental Anesthesia Anesthesia, Local Anesthesia, Reversal

Start date: 2012-02-01
Primary completion: 2014-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.